The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC).
- DOI
- 10.1590/1414-431x20177214
- Published
- 2018 Jan 11
- Container
- Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1590/1414-431x20177214,
title = {The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC).},
author = {Fernandes GS and Sternberg C and Lopes G and Chammas R and Gifoni MAC and Gil RA and Araujo DV},
year = {2018},
journal = {Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas},
doi = {10.1590/1414-431x20177214},
url = {https://doi.org/10.1590/1414-431x20177214}
}RIS
TY - JOUR TI - The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC). AU - Fernandes GS AU - Sternberg C AU - Lopes G AU - Chammas R AU - Gifoni MAC AU - Gil RA AU - Araujo DV PY - 2018 JO - Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas DO - 10.1590/1414-431x20177214 UR - https://doi.org/10.1590/1414-431x20177214 ER -
APA
GS, F., C, S., G, L., R, C., MAC, G., RA, G., & DV, A. (2018). The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC).. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. https://doi.org/10.1590/1414-431x20177214
Source records
- pubmed · retrieved 2026-09-27T14:03:15.952Z